Tracer Biotechnologies
Pre-clinicalTransform any sequencer or dPCR into a single-ppm cancer-radar—tissue-free, immediate, and accessible.
Founded
2020
Focus
AI / Machine LearningProteomics
About
Transform any sequencer or dPCR into a single-ppm cancer-radar—tissue-free, immediate, and accessible.
Funding History
1Total raised: $3M
Seed$3MUndisclosedNov 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile